United Therapeutics Grants & Scientific Sponsorships

Medical Education Grants and Scientific Sponsorships

United Therapeutics Corporation recognizes the importance of, and is committed to, providing grant support to educate healthcare professionals and enhance patient care.

To ensure that every request is thoroughly reviewed, and all applicant questions are answered, please submit requests to United Therapeutics at least 60 days prior to the program start date.

Types of Activities We Support

Medical Education Grants

Funding provided by United Therapeutics to an independent third party for scientific or medical educational activities (either accredited or non-accredited) that are non-promotional and developed by the third party without influence or control from United Therapeutics.

Funding is available for the following medical education objectives:

Improve understanding of the pathophysiology, prevalence, and burden of illness of IPF. Recognize unmet needs, barriers to treatment uptake and tolerability challenges associated with currently available therapies, and potential role and mechanism of action for emerging therapies to IPF.
Understand how the presence of PH impacts outcomes of patients with ILD; enhance understanding of screening, timely diagnosis, and clinical management of PH-ILD and IPF. Understand patterns for transplant referral and evaluation.
Recognize the importance of routine and formal risk assessment in PAH patients and the triggers and timing of therapy escalation, particularly in special populations (eg, CTD patients), as well as the need to achieve low risk status or hemodynamic remission.
Understand the hemodynamics associated with PH and how different classes of therapies impact hemodynamic parameters.
Improve patient selection and management of adverse events associated with various PH and IPF therapies, particularly prostacyclin-class therapies, to increase persistence on therapy.
Evaluate the clinical data associated with therapeutic transitions in PAH and how they apply to clinical practice.

For medical education and scientific sponsorship questions, please email MedEdGrants@unither.com.

Feedback to Your Organization

Once you submit your application, you will receive automatic notifications from United Therapeutics as follows:

Email notification providing confirmation that your application has been successfully submitted for review.
Email notification upon completion of the review process, indicating whether your application was either accepted for funding or not funded.

To submit a request, please visit:

www.UTCRequests.com

Have a question?

Medical affairs professionals are available to help with questions regarding UT products.

Call us at: 1-877-522-2950

To report suspected adverse reactions contact United Therapeutics
1-866-458-6479

or FDA at
1-800-FDA-1088 or www.fda.gov/medwatch

...or submit a request for information.

This form is intended to be used by research and healthcare professionals. If you are not a research or healthcare professional, please click here.

First Name*

Last Name*

Email*

Phone*

Professional Designation*

NPI or License Number*

Address*

State*

City*

Zip Code*

Preferred Method of Contact*

Product*

Specialty*

Question or Request

By clicking the “Submit” button, I attest that I am the research or healthcare professional stated above and confirm that this is an unsolicited request.

The information you provide will be treated in accordance with United Therapeutics Corporation’s Privacy Policy.